A global view of undergraduate education in pharmacovigilance.
OBJECTIVE
The aim of this study was to gain insight in current pharmacovigilance educational activities and to gather information on which topics should be included in the undergraduate pharmacovigilance core curriculum.


METHODS
A web-based questionnaire was carried out containing 45 questions divided over four sections between 28 October 2014 and 31 January 2015. Potential participants working in pharmacovigilance and/or providing training in this field were invited via email and a widespread web link and snowball sampling was used to recruit additional participants.


RESULTS
The questionnaire was filled out by 307 respondents from 88 different countries with a response rate of 29.3% for the email invitation and an unknown rate for the web link. Respondents were mainly pharmacists and physicians. Currently, lectures are the largest proportion of educational activities and all healthcare profession curricula have a mode of 2 h as number of contact hours per course. Respondents rated clinical aspects as the most important subdomain to be included in the core curriculum with prevention of adverse drug reactions as the most important subtopic. This was followed by communication aspects between parties, with communication between regulatory authorities and healthcare professionals, methodological aspects with causality assessment, and regulatory aspects with benefit-risk assessment. This is similar to subjects addressed in current educational activities with little difference between medical and pharmacy curricula.


CONCLUSIONS
This study gave a good general impression in current educational activities and the respondents' needs and wishes for future activities worldwide, which both will be used for the development of the undergraduate pharmacovigilance core curriculum.
Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands. jenny_hartman@hotmail.com.
Jenny
J
Hartman
Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands.
Linda
L
Härmark
Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands.|Faculty of Mathematics and Natural Sciences, PharmacoTherapy, -Epidemiology and -Economics-Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Eugène
E
van Puijenbroek
D004504:Education, Medical, Undergraduate; D006801:Humans; D010595:Pharmacists; D060735:Pharmacovigilance; D010820:Physicians; D011795:Surveys and Questionnaires
Curriculum; Education; Pharmacovigilance; Survey; Undergraduate